麻豆果冻传媒影音

Provisional CDC estimates showed the high since 1941 and was an age-adjusted 1% higher than in 2021.

The FDA accepted Karuna Therapeutics' new drug application for its investigational (KarXT) along with the EMERGENT clinical trial data, with a decision expected by September 2024.

Two doses of of people with moderate-to-severe major depressive disorder, said Xenon Pharmaceuticals.

Meanwhile, BioVie blamed as the reason why its investigational Alzheimer's disease drug NE3107 failed a phase III trial.

In the randomized SELFIE trial from Germany, a novel transdiagnostic ecological momentary intervention outcomes. (JAMA Psychiatry)

Only 39% of young adults ages 18 to 24 for at least 5 years. (The Lancet Psychiatry)

The American Psychological Association issued a new report detailing the and how to combat it.

Breast cancer screening completion was lower among , a case-control study in Canada showed. (JAMA Network Open)

The PSYCHE study found that were susceptible to both depression and parenting stress. (JAMA Network Open)

Serious that led to medication cessation usually occurred within 18 weeks of starting treatment, a retrospective study found. (The Lancet Psychiatry)

A two-decade found no evidence that using cannabis reduced . (American Journal of Psychiatry, The Guardian)

Adults who had a had a higher rate of newly treated depression and a lower risk of psychiatric hospitalization than their unscreened counterparts, a study from Taiwan found. (The Lancet Regional Health Western Pacific)

Nurses at asked for immediate help following reports of violence at the Psychiatry and Behavioral Medicine Unit. (Washington State Nurses Association)

Comment